These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1229 related items for PubMed ID: 15072750

  • 1. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES, Lambert JS, Watson DC, Afonso AO, da Cunha SM, Nogueira SA, Caride E, Oliveira RH, Sill AM, DeVico A, Tanuri A.
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B, ANRS CO3 Aquitaine Cohort.
    AIDS; 2008 Jul 31; 22(12):1417-23. PubMed ID: 18614864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C, Martín-Carbonero L, Gallego O, Corral A, González-Lahoz J, Soriano V.
    J Med Virol; 2005 May 31; 76(1):1-6. PubMed ID: 15778973
    [Abstract] [Full Text] [Related]

  • 12. Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.
    Pilcher CD, Perkins MD, Fiscus SA, Johnston DM, Dietze R, Duque UH, Zago AM, Assad-Antunes F, Eron JJ.
    J Infect Dis; 1999 May 31; 179(5):1259-63. PubMed ID: 10191233
    [Abstract] [Full Text] [Related]

  • 13. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.
    Indian J Med Microbiol; 2009 May 31; 27(3):231-6. PubMed ID: 19584504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
    Izopet J, Marchou B, Charreau I, Sauné K, Tangre P, Molina JM, Aboulker JP, Window (ANRS 106) Study Team.
    Antivir Ther; 2008 May 31; 13(4):537-45. PubMed ID: 18672532
    [Abstract] [Full Text] [Related]

  • 17. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L, Nicastri E, Montano M, Dori L, Buonomini AR, d'Ettorre G, Gatti F, Parisi SG, Vullo V, Andreoni M.
    J Med Virol; 2004 Apr 31; 72(4):511-6. PubMed ID: 14981751
    [Abstract] [Full Text] [Related]

  • 18. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S, Ledergerber B, Böni J, Schüpbach J, Kronenberg A, Opravil M, Flepp M, Speck RF, Grube C, Rentsch K, Weber R, Günthard HF, Swiss HIV Cohort Study.
    Antivir Ther; 2003 Oct 31; 8(5):443-54. PubMed ID: 14640392
    [Abstract] [Full Text] [Related]

  • 19. Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children.
    Lambert JS, Machado ES, Watson DC, Sill AM, Lim JK, Charurat M, Cunha SM, Afonso AO, Oliviera RH, Tanuri A, DeVico AL.
    Pediatr Infect Dis J; 2007 Oct 31; 26(10):935-44. PubMed ID: 17901800
    [Abstract] [Full Text] [Related]

  • 20. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S, Zazzi M, Corsi P, Gonnelli A, Di Pietro M, Giacometti A, Almi P, Trezzi M, Boeri E, Gianotti N, Menzo S, Del Gobbo R, Francisci D, Nerli A, Galli L, De Luca A, Antiretroviral Resistance Cohort Analysis Study Group.
    Antivir Ther; 2009 Oct 31; 14(3):359-69. PubMed ID: 19474470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.